S(+)-ibuprofen destabilizes MYC/MYCN and AKT, increases p53 expression, and induces unfolded protein response and favorable phenotype in neuroblastoma cell lines

By                

International Journal of Oncology, Vol. 44, Iss. 1, 2014-01 ,pp. : 35-43

Spandidos Publications

Access to resources Recommend Favorite

Clinical relevance of CD44 cell surface expression and MYCN gene amplification in neuroblastoma

By Combaret V.   Gross N.   Lasset C.   Frappaz D.   Beretta-Brognara C.   Philip T.   Beck D.   Favrot M.C.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 2101-2105

Elsevier

Access to resources Recommend Favorite

HuD, a neuronal-specific RNA-binding protein, is a potential regulator of MYCN expression in human neuroblastoma cells

By Ross R.A.   Lazarova D.L.   Manley G.T.   Smitt P.S.   Spengler B.A.   Posner J.B.   Biedler J.L.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 2071-2074

Elsevier

Access to resources Recommend Favorite

Microarray data analysis of neuroblastoma: Expression of SOX2 downregulates the expression of MYCN

By              

Molecular Medicine Reports, Vol. 12, Iss. 5, 2015-01 ,pp. : 6867-6872

Spandidos Publications

Access to resources Recommend Favorite

Evidence that the MYCN oncogene regulates MRP gene expression in neuroblastoma

By Norris M.D.   Bordow S.B.   Haber P.S.   Marshall G.M.   Kavallaris M.   Madafiglio J.   Cohn S.L.   Salwen H.   Schmidt M.L.   Hipfner D.R.   Cole S.P.C.   Deeley R.G.   Haber M.  

European Journal of Cancer, Vol. 33, Iss. 12, 1997-10 ,pp. : 1911-1916

Elsevier

Access to resources Recommend Favorite